We Invest In Exceptional People & Impactful Products
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.
See Our Purpose
Our Areas Of Interest For Investment
Our overarching thesis is that technology will transform all sectors of our world and that biggest transformations are yet to come. Every few years there are new frontiers opening for innovation.
See Our Purpose
110 New and Follow-on
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.
You Can Measure Our Success In Numbers
Our overarching thesis is that technology will transform all sector of our world and that is biggest transformation are yet to come. Every few years there are new frontiers opening for innovation.
Mergers & Acquisitions
IPOs Management
Team Members
Products Braught To Market
Companies have reached ≥ $1B valuation
David Miller Watson
Product Manager
Victor James Warren
CEO & FounderWe Have Excellent Team Members To Meet With You
Our overarching thesis is that technology will transform all sectors our world and that the biggest transformation are yet to come. Every few years there are new frontiers opening for innovation.You will observe this now & later.
John Smilga Tobby
Product Developer
Jonathon Ronan Andy
Investor
Jennifer Lorence Watson
Investor
What Clients Say About Us
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.
Olivar Lucy
CEO of Gameto Pharmaceuticals
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.
Jane Ronan
MD of San Atlas Ltd
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.
Chris Haris
CFO of Olly Corp.
Read Latest News Of Ventures
Our overarching thesis is that technology will transform all sectors of our world and that the biggest transformations are yet to come. Every few years there are new frontiers opening for innovation.
Visit Blog Page
